Why the study?
To describe anticoagulant treatment experiences for eliminating significant left ventricular thrombosis during extracorporeal membrane oxygenation without surgery.
Anticoagulant therapy may be a viable non-surgical option for treating large left ventricular thrombosis in patients on VA-ECMO.
We report a rare complication of left ventricular giant thrombus in a patient with fulminant myocarditis after venoarterial extracorporeal membrane oxygenation therapy. This case report offers simple anticoagulant treatment experiences to eliminate significant LV thrombosis in patient undergoing extracorporeal membrane oxygenation, so that patients do not need surgery.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: